IBioIC funded feasibility study
TAC recently completed a feasibility study on the “Selection and characterisation of anti-peptide synthetic antibodies for comparison with conventional reagents”, funded by IBioIC. Read all about it here
May 2023
ELRIG – THE SCOTTISH RESEARCH AND DRUG DEVELOPMENT FORUM
TAC was invited to give a talk on novel antibody production at the most recent ELRIG conference. Dr Jack Bryson presented “Production of Monoclonal Antibodies using a Phage-Display scFv Library: a Faster, More Flexible, and More Secure Complement to Hybridoma”. This generated a lot of discussion with some very interesting proposals for projects utilising this …
ELRIG – THE SCOTTISH RESEARCH AND DRUG DEVELOPMENT FORUM Read More »
North Lanarkshire Council employer award for The Antibody Company
The Antibody Company, TAC, has been recognised for high standards of excellence with silver accreditation from North Lanarkshire Council’s Employer Charter. The charter is based around four commitments by employers: to pay all staff at minimum the Real Living Wage; employ North Lanarkshire residents; use local businesses in the supply chain where possible; and ensure fair work practices …
North Lanarkshire Council employer award for The Antibody Company Read More »